{
  "actions": [
    {
      "acted_at": "2011-05-25",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2011-05-25",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2011-06-03",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hres279-112",
  "bill_type": "hres",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "112",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2011-05-25",
  "number": "279",
  "official_title": "Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "C001058",
    "district": "6",
    "name": "Chandler, Ben",
    "state": "KY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2011-05-25",
  "subjects": [
    "Health",
    "Health promotion and preventive care",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2011-05-25",
    "date": "2011-06-22T15:47:05Z",
    "text": "Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.\n\nEncourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.",
      "type": "official"
    }
  ],
  "updated_at": "2019-11-15T21:21:16Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/112/hres/BILLSTATUS-112hres279.xml"
}